The course provides the basics of cell signaling and how the cell division is controlled in the multicellular organisms. The course discusses each signaling pathway and the targeted therapies developed for it. Importantly, the course focuses on delivering the real-life examples from clinical trials so that the participant can have a robust idea on the benefits that the targeted therapies provide while being aware of the challenges that face the medical field. The participant at the end of the course has to know that there is no silver bullet for all cancers, not only that but also how the pharmaceutical industry shifted their focus from the histological segmentation of patients to the genomic one, which then rewarded them with better results and more drug approvals that tend to reach up to 40% from total fda approved drugs each year. Last but not least, the participant in that course will get familiar with several side effects of the inhibition of certain pathways, and how the same pathway can lead to different outcomes in different cell types.
The course provides the basics of cell signaling and how the cell division is controlled in the multicellular organisms. The course discusses each signaling pathway and the targeted therapies developed for it. Importantly, the course focuses on delivering the real-life examples from clinical trials so that the participant can have a robust idea on the benefits that the targeted therapies provide while being aware of the challenges that face the medical field. The participant at the end of the course has to know that there is no silver bullet for all cancers, not only that but also how the pharmaceutical industry shifted their focus from the histological segmentation of patients to the genomic one, which then rewarded them with better results and more drug approvals that tend to reach up to 40% from total fda approved drugs each year. Last but not least, the participant in that course will get familiar with several side effects of the inhibition of certain pathways, and how the same pathway can lead to different outcomes in different cell types.
The course will discuss only the In addition, the course will discuss several well known oncogenic mutations in the receptors and their targeted therapies.
This course was brought to you by : Radwan Derbala
Participated in Montage : Mostafa Saad
Participated in some designs: Radwa Omar
Verified partner policies & purchase protections
Free preview video lectures available for all courses; optional 7-day free trial on Personal Plan subscriptions (cancel before trial ends to avoid conversion).
30-day money-back guarantee on all eligible individual course purchases (provided course content has not been substantially consumed or downloaded). Subscription fees are non-refundable once billed.
Lifetime access to purchased individual courses and future updates, verifiable certificate of completion, and direct student Q&A forums.
OpenCourser helps millions of learners each year. People visit us to learn workspace skills, ace their exams, and nurture their curiosity.
Our extensive catalog contains over 50,000 courses and twice as many books. Browse by search, by topic, or even by career interests. We'll match you to the right resources quickly.
Find this site helpful? Tell a friend about us.
We're supported by our community of learners. When you purchase or subscribe to courses and programs or purchase books, we may earn a commission from our partners.
Your purchases help us maintain our catalog and keep our servers humming without ads.
Thank you for supporting OpenCourser.